DV
Dividend Vision

CTKB — Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

Total return is -75.0% over the past 5.1 years, 163.8 points behind SPY at 88.8%. Its deepest 1-year drawdown was 42.9%.

CTKB is an equity fund focused on Cytek Biosciences Inc, a single-stock holding in the biotechnology sector. The fund does not currently offer distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This structure appeals primarily to growth-oriented investors seeking exposure to a specific biotech company rather than those prioritizing yield.

CTKB key facts

Asset type
Stock
Asset class
Equity
Inception date
07/23/2021
Last close
$4.69
Market cap
$596,638,720
Average volume
927484.0
Beta
1.171
Payout ratio
0.0
Forward P/E
370.3704
EPS
$-0.58